Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Letters to the Editor

Diabetic retinopathy: Screening, prevention, and treatment

Ashley Lim
Cleveland Clinic Journal of Medicine December 2024, 91 (12) 723; DOI: https://doi.org/10.3949/ccjm.91c.12001
Ashley Lim
University College Dublin, Belfield, Dublin
Roles: Medical Student
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

To the Editor: I read with great interest the review on diabetic retinopathy by Dr. Chong and colleagues1 published in the August 2024 issue of the Journal. The article rightly emphasizes the pivotal role of primary care physicians in managing diabetic retinopathy through early detection and referrals. However, there are additional facets of diabetes care that deserve attention to further reduce the growing burden of this disease.

The authors emphasize the importance of glycemic control in preventing diabetic retinopathy. The article, however, could further explore the impact of new therapies, such as sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists, which have shown promise in managing diabetes but have complex interactions with diabetic retinopathy.2 Recent studies have highlighted potential early worsening of retinopathy when rapid glycemic control is achieved using these agents.3 Further discussion of this phenomenon could provide clinicians with a more nuanced understanding of the risks and benefits of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists.

The section on artificial intelligence in diabetic retinopathy screening could be expanded regarding the limitations of artificial intelligence tools. While systems that use artificial intelligence to identify diabetic retinopathy are promising, concerns about lower specificity and inappropriate referrals are noted in other reviews.4 A broader discussion of these limitations, as well as practical solutions, would aid in implementing such systems in clinical practice.

In summary, the authors have skillfully compiled important information on diabetic retinopathy, providing valuable guidance for clinicians treating patients with diabetes. Their thorough coverage of screening, prevention, and treatment offers critical insights. I commend their work and look forward to future updates and discussions on advancing management strategies and applying these insights in everyday clinical practice.

  • Copyright © 2024 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Chong DD,
    2. Das N,
    3. Singh RP
    . Diabetic retinopathy: screening, prevention, and treatment. Clev Clin J Med 2024; 91(8):503–510. doi:10.3949/ccjm.91a.24028
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Wai KM,
    2. Mishra K,
    3. Koo E, et al
    . Impact of GLP-1 agonists and SGLT-2 inhibitors on diabetic retinopathy progression: an aggregated electronic health record data study. Am J Ophthalmol 2024; 265:39–47. doi:10.1016/j.ajo.2024.04.010
    OpenUrlCrossRefPubMed
  3. ↵
    1. Jingi AM,
    2. Tankeu AT,
    3. Ateba NA,
    4. Noubiap JJ
    . Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis. BMC Endocr Disord 2017; 17(1):63. doi:10.1186/s12902-017-0213-3
    OpenUrlCrossRefPubMed
  4. ↵
    1. Lim JI,
    2. Regillo CD,
    3. Sadda SR, et al
    . Artificial intelligence detection of diabetic retinopathy: subgroup comparison of the EyeArt system with ophthalmologists’ dilated examinations. Ophthalmol Sci 2022; 3(1):100228. doi:10.1016/j.xops.2022.100228
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 91 (12)
Cleveland Clinic Journal of Medicine
Vol. 91, Issue 12
1 Dec 2024
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diabetic retinopathy: Screening, prevention, and treatment
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
Please verify that you are a real person.
Citation Tools
Diabetic retinopathy: Screening, prevention, and treatment
Ashley Lim
Cleveland Clinic Journal of Medicine Dec 2024, 91 (12) 723; DOI: 10.3949/ccjm.91c.12001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Diabetic retinopathy: Screening, prevention, and treatment
Ashley Lim
Cleveland Clinic Journal of Medicine Dec 2024, 91 (12) 723; DOI: 10.3949/ccjm.91c.12001
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • In Reply: In defense of the anion gap
  • In defense of the anion gap
  • Insomnia in older adults
Show more Letters to the editor

Similar Articles

Subjects

  • Diabetes
  • Endocrinology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire